person · Reporting owner
Phelan William Lawrence
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LUNA INNOVATIONS INCLUNA · Entity 84494 | Chief Financial Officer | October 16, 2024 | October 21, 2024 |
| MIMEDX GROUP, INC.MDXG · Entity 5271 | Chief Accounting Officer | May 10, 2023 | May 12, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LUNA INNOVATIONS INC
Report date October 16, 2024 · Filed October 21, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 150,000 |
Reported balance
After 2024-10-16 transaction · row 1
1 source rowRow 1 · 2024-10-16 · Grant · Acquired 150,000 · Balance 150,000 F1: This transaction is being reported late due to an administrative error. F2: Consists of restricted stock units. Each restricted stock unit represents the contingent right to receive one share of common stock of the Issuer. The restricted stock units vest in one installment on October 16, 2025, subject to the Reporting Person's continued service with the Company through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction is being reported late due to an administrative error.
F2: Consists of restricted stock units. Each restricted stock unit represents the contingent right to receive one share of common stock of the Issuer. The restricted stock units vest in one installment on October 16, 2025, subject to the Reporting Person's continued service with the Company through such vesting date.
MIMEDX GROUP, INC.
Report date May 10, 2023 · Filed May 12, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 184,219 |
Reported balance
After 2023-05-10 transaction · row 1
1 source rowRow 1 · 2023-05-10 · Sale · Disposed 1,595 · Balance 184,219 F1: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 16, 2024 Filed Oct 21, 2024 17:12 UTC | LUNA INNOVATIONS INC LUNA · Entity 84494 | GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001239819-24-000120 · wk-form4_1729545139.xml · nonDerivative · entry 1 Phelan William Lawrence · CIK 0001811814 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 F1 · shares: This transaction is being reported late due to an administrative error. F2 · shares: Consists of restricted stock units. Each restricted stock unit represents the contingent right to receive one share of common stock of the Issuer. The restricted stock units vest in one installment on October 16, 2025, subject to the Reporting Person's continued service with the Company through such vesting date. Read SEC document |
| May 10, 2023 Filed May 12, 2023 22:53 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 1,595 | $5.93 | $9,452.13 |
DisclosureSEC source: 0001376339-23-000026 · wf-form4_168393199972917.xml · nonDerivative · entry 1 Phelan William Lawrence · CIK 0001811814 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,219 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| May 02, 2023 Filed May 3, 2023 22:26 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 5,200 | $3.80 | $19,739.20 |
DisclosureSEC source: 0001376339-23-000018 · wf-form4_168315278769141.xml · nonDerivative · entry 1 Phelan William Lawrence · CIK 0001811814 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,814 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. F2 · price: The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $3.790 to $3.805, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 23:25 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 1,628 | $3.74 | $6,095.23 |
DisclosureSEC source: 0001628280-23-013698 · wf-form4_168263789367161.xml · nonDerivative · entry 1 Phelan William Lawrence · CIK 0001811814 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,014 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| April 11, 2023 Filed Apr 13, 2023 21:52 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 1,632 | $3.31 | $5,401.92 |
DisclosureSEC source: 0001628280-23-011534 · wf-form4_168142272664297.xml · nonDerivative · entry 1 Phelan William Lawrence · CIK 0001811814 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,642 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 22:19 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 53,030 | $4.62 | $244,998.60 |
DisclosureSEC source: 0001376339-23-000006 · wf-form4_167891873589626.xml · nonDerivative · entry 1 Phelan William Lawrence · CIK 0001811814 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,274 F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Grant is exempt under Rule 16b-3. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 22:42 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 3,396 | $4.24 | $14,414.66 |
DisclosureSEC source: 0001376339-23-000004 · wf-form4_167840175468517.xml · nonDerivative · entry 1 Phelan William Lawrence · CIK 0001811814 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,244 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| May 06, 2022 Filed May 10, 2022 20:47 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 5,750 | $3.81 | $21,907.50 |
DisclosureSEC source: 0001376339-22-000070 · wf-form4_165221564361153.xml · nonDerivative · entry 1 Phelan William Lawrence · CIK 0001811814 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,640 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 21:27 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 53,030 | $4.62 | $244,998.60 |
DisclosureSEC source: 0001376339-22-000041 · wf-form4_164979882503804.xml · nonDerivative · entry 1 Phelan William Lawrence · CIK 0001811814 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,390 F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Grant is exempt under Rule 16b-3. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 21:20 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 3,268 | $4.86 | $15,879.21 |
DisclosureSEC source: 0001376339-22-000020 · wf-form4_164694718293968.xml · nonDerivative · entry 1 Phelan William Lawrence · CIK 0001811814 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,360 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.75 to $4.965, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| May 01, 2021 Filed May 3, 2021 20:33 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 5,433 | $9.70 | $52,700.10 |
DisclosureSEC source: 0001811814-21-000004 · wf-form4_162007402129472.xml · nonDerivative · entry 1 Phelan William Lawrence · CIK 0001811814 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,154 F1 · kind: This transaction represents the netting of shares to pay applicable withholding upon vesting of previously-granted award. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 21:24 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 29,791 | $0.00 | $0.00 |
DisclosureSEC source: 0001811814-21-000002 · wf-form4_161523863814370.xml · nonDerivative · entry 1 Phelan William Lawrence · CIK 0001811814 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,587 F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Read SEC document |
| November 04, 2020 Filed Nov 5, 2020 21:08 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 8,474 | $7.23 | $61,267.02 |
DisclosureSEC source: 0001811814-20-000004 · wf-form4_160461036771439.xml · nonDerivative · entry 1 Phelan William Lawrence · CIK 0001811814 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,796 F1 · date: Represents vesting upon satisfaction of performance criterion with respect to previously-granted performance based restricted stock units. Read SEC document |
| August 05, 2020 Filed Aug 6, 2020 20:50 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 59,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001811814-20-000002 · wf-form4_159674703227789.xml · nonDerivative · entry 1 Phelan William Lawrence · CIK 0001811814 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,322 F1 · security: On August 5, 2020, the Company fixed the number of shares subject to a previously-awarded restricted stock units based on the closing stock price on that date ($5.90). Award will be settled in common stock upon vesting. One-third of the award vests upon each anniversary of the original grant date, May 1, 2020. Grant is exempt under Rule 16b-3. F1 · price: On August 5, 2020, the Company fixed the number of shares subject to a previously-awarded restricted stock units based on the closing stock price on that date ($5.90). Award will be settled in common stock upon vesting. One-third of the award vests upon each anniversary of the original grant date, May 1, 2020. Grant is exempt under Rule 16b-3. Read SEC document |
| July 06, 2020 Filed Mar 10, 2022 21:19 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 8,474 | $5.40 | $45,759.60 |
DisclosureSEC source: 0001376339-22-000019 · wf-form4_164694712837864.xml · nonDerivative · entry 1 Phelan William Lawrence · CIK 0001811814 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,628 F1 · shares: Represents vesting upon satisfaction of performance criterion with respect to previously-granted performance vested restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.